Stay updated with breaking news from Trinetx Analytics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Scientists analyzed the differences between SARS-CoV-2 rebound associated with the Omicron BA.2.12.1 and BA.5 sublineages post-Paxlovid therapy in the United States.
In a recent article posted to the medRxiv* preprint server, investigators in the United States illustrated that rebound of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can occur in some patients following molnupiravir and Paxlovid SARS-CoV-2 therapy.
All subtypes of interstitial lung disease — except for Sjogren’s syndrome — increase mortality from COVID-19.
All subtypes of interstitial lung disease — except for Sjogren’s syndrome — increase mortality from COVID-19.
The risk of breakthrough SARS-CoV-2 infection in vaccinated cancer patients varies by cancer type, a large study suggests.